초록 ▼

The invention relates to implantable bioprostheses (e.g. implantable biological tissues) and to compositions and methods for stabilizing them. Implantable bioprostheses stabilized as described herein exhibit improved mechanical properties and reduced post-implantation calcification. The implantable

The invention relates to implantable bioprostheses (e.g. implantable biological tissues) and to compositions and methods for stabilizing them. Implantable bioprostheses stabilized as described herein exhibit improved mechanical properties and reduced post-implantation calcification. The implantable bioprosthesis is made by contacting a bioprosthesis (e.g. a tissue obtained from an animal or an article comprising a tissue and a synthetic material) with a polyepoxy amine compound.

대표청구항 ▼

1. A method of manufacturing an implantable bioprosthesis, the method comprising:providing the bioprosthesis comprising proteins;providing a first stabilizing reagent which is a polyepoxy amine compound; andcontacting the bioprosthesis and the polyepoxy amine compound, whereby the bioprosthesis is m

1. A method of manufacturing an implantable bioprosthesis, the method comprising:providing the bioprosthesis comprising proteins;providing a first stabilizing reagent which is a polyepoxy amine compound; andcontacting the bioprosthesis and the polyepoxy amine compound, whereby the bioprosthesis is manufactured. 2. An implantable bioprosthesis manufactured by the method of claim 1, wherein the bioprosthesis comprises the proteins cross-linked by contacting the bioprosthesis with the polyepoxy amine compound. 3. The implantable bioprosthesis of claim 2, wherein the bioprosthesis is contacted with the polyepoxy amine compound in an aqueous liquid having a pH of about 6 to 10. 4. The implantable bioprosthesis of claim 2, wherein the proteins are cross-linked by contacting the bioprosthesis with the polyepoxy amine compound in an aqueous liquid having a pH of about 7 to 10. 5. The implantable bioprosthesis of claim 2, wherein the proteins are cross-linked by contacting the bioprosthesis with the polyepoxy amine compound in an aqueous liquid having a pH of about 7.0 to 7.4. 6. The implantable bioprosthesis of claim 2, wherein the polyepoxy amine compound is triglycidyl amine. 7. The implantable bioprosthesis of claim 2, wherein the proteins are cross-linked by contacting the polyepoxy amine compound with moieties of the proteins which are members independently selected from the group consisting of a methylthio moiety, a primary amine moiety, a phenolic hydroxyl moiety, a phosphate moiety, and a carboxyl moiety. 8. The implantable bioprosthesis of claim 2, wherein the implantable bioprosthesis is treated with a second stabilization reagent. 9. The implantable bioprosthesis of claim 8, wherein the second stabilization reagent is a cross-linking reagent. 10. The implantable bioprosthesis of claim 8, wherein the second stabilization reagent is a calcification inhibitor. 11. The implantable bioprosthesis of claim 10, wherein the calcification inhibitor is aluminum chloride. 12. The implantable bioprosthesis of claim 8, wherein the second stabilization reagent is a glycosaminoglycan-stabilizing reagent. 13. The implantable bioprosthesis of claim 12, wherein the glycosaminoglycan-stabilizing reagent is a carbodiimide.